Laleman W - Search Results

1

The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations.

Meersseman P, Langouche L, du Plessis J, Korf H, Mekeirele M, Laleman W, Nevens F, Wilmer A, Van den Berghe G, van der Merwe SW. Meersseman P, et al. Among authors: laleman w. J Hepatol. 2018 Oct;69(4):803-809. doi: 10.1016/j.jhep.2018.04.025. Epub 2018 May 4. J Hepatol. 2018. PMID: 29730473

2

Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure.

Evenepoel P, Laleman W, Wilmer A, Claes K, Maes B, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y. Evenepoel P, et al. Among authors: laleman w. Blood Purif. 2005;23(5):349-58. doi: 10.1159/000086885. Epub 2005 Jul 11. Blood Purif. 2005. PMID: 16020951

3

A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.

Laleman W, Omasta A, Van de Casteele M, Zeegers M, Vander Elst I, Van Landeghem L, Severi T, van Pelt J, Roskams T, Fevery J, Nevens F. Laleman W, et al. Hepatology. 2005 Dec;42(6):1382-90. doi: 10.1002/hep.20968. Hepatology. 2005. PMID: 16317694

4

Portal hypertension: from pathophysiology to clinical practice.

Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F. Laleman W, et al. Liver Int. 2005 Dec;25(6):1079-90. doi: 10.1111/j.1478-3231.2005.01163.x. Liver Int. 2005. PMID: 16343056 Review.

5

Review article: non-biological liver support in liver failure.

Laleman W, Wilmer A, Evenepoel P, Verslype C, Fevery J, Nevens F. Laleman W, et al. Aliment Pharmacol Ther. 2006 Feb 1;23(3):351-63. doi: 10.1111/j.1365-2036.2006.02765.x. Aliment Pharmacol Ther. 2006. PMID: 16422994 Review.

6

A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.

Laleman W, Vander Elst I, Zeegers M, Servaes R, Libbrecht L, Roskams T, Fevery J, Nevens F. Laleman W, et al. Eur J Clin Invest. 2006 Apr;36(4):242-9. doi: 10.1111/j.1365-2362.2006.01620.x. Eur J Clin Invest. 2006. PMID: 16620286

7

Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.

Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y. Evenepoel P, et al. Among authors: laleman w. Artif Organs. 2006 Apr;30(4):276-84. doi: 10.1111/j.1525-1594.2006.00215.x. Artif Organs. 2006. PMID: 16643386

8

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.

Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F. Laleman W, et al. Crit Care. 2006;10(4):R108. doi: 10.1186/cc4985. Crit Care. 2006. PMID: 16859530 Free PMC article. Clinical Trial.

9

Both Ca2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine.

Laleman W, Van Landeghem L, Severi T, Vander Elst I, Zeegers M, Bisschops R, Van Pelt J, Roskams T, Cassiman D, Fevery J, Nevens F. Laleman W, et al. Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G556-64. doi: 10.1152/ajpgi.00196.2006. Epub 2006 Sep 28. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 17008556 Free article.

10

Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.

Laleman W, Nevens F. Laleman W, et al. Minerva Med. 2006 Aug;97(4):325-45. Minerva Med. 2006. PMID: 17008837 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters